28 Mar 2024
07:00 CET |
EUROAPI SA |
Document d’Enregistrement Universel 2023
|
20103015 Pharmaceuticals |
Other subject |
28 Mar 2024
07:00 CET |
EUROAPI SA |
2023 Universal Registration Document
|
20103015 Pharmaceuticals |
Other subject |
14 Mar 2024
18:55 CET |
EUROAPI SA |
Perspectives 2024 suspendues à la suite de l’arrêt temporaire de production d’API sur le site de Brindisi en Italie
|
20103015 Pharmaceuticals |
Other subject |
14 Mar 2024
18:55 CET |
EUROAPI SA |
Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy
|
20103015 Pharmaceuticals |
Other subject |
28 Feb 2024
19:16 CET |
EUROAPI SA |
Résultats annuels 2023
|
20103015 Pharmaceuticals |
Other subject |
28 Feb 2024
19:16 CET |
EUROAPI SA |
Full-year 2023 results
|
20103015 Pharmaceuticals |
Other subject |
25 Jan 2024
07:00 CET |
EUROAPI SA |
EUROAPI Enhances Its CDMO Capabilities Through a Pivotal Collaboration With SpiroChem, a Leading Contract Research Organization (CRO)
|
20103015 Pharmaceuticals |
Other subject |
25 Jan 2024
07:00 CET |
EUROAPI SA |
EUROAPI enrichit ses compétences en CDMO grâce à une collaboration essentielle avec SpiroChem, une Contract Research Organization (CRO) de premier plan
|
20103015 Pharmaceuticals |
Other subject |
04 Jan 2024
17:45 CET |
EUROAPI SA |
EUROAPI renforce son Comité Exécutif en nommant Ludwig de Mot Directeur Général Adjoint, en charge de la transformation de l’entreprise
|
20103015 Pharmaceuticals |
Other subject |
04 Jan 2024
17:45 CET |
EUROAPI SA |
EUROAPI Strengthens its Executive Committee with the Appointment of Ludwig de Mot as Executive Vice President - Chief Transformation Officer
|
20103015 Pharmaceuticals |
Other subject |
28 Nov 2023
08:00 CET |
EUROAPI SA |
EUROAPI Appoints New Executive Committee Members
|
20103015 Pharmaceuticals |
Other subject |
28 Nov 2023
08:00 CET |
EUROAPI SA |
EUROAPI nomme de nouveaux membres au Comité Exécutif
|
20103015 Pharmaceuticals |
Other subject |
21 Nov 2023
17:45 CET |
EUROAPI SA |
CDMO : EUROAPI finalise l’acquisition de Biano
|
20103015 Pharmaceuticals |
Other subject |
21 Nov 2023
17:45 CET |
EUROAPI SA |
CDMO: EUROAPI Completes Acquisition of Biano
|
20103015 Pharmaceuticals |
Other subject |
30 Oct 2023
18:38 CET |
EUROAPI SA |
EUROAPI: Information Relating to the Financial Terms of the Departure of the Chief Executive Officer and the Appointment of the Chairman of the Board as Interim Chief Executive Officer
|
20103015 Pharmaceuticals |
Other subject |
30 Oct 2023
18:38 CET |
EUROAPI SA |
EUROAPI : Information relative aux conditions financières du départ du Directeur Général et de la nomination de la Présidente du Conseil d’Administration comme Directrice Générale par intérim
|
20103015 Pharmaceuticals |
Other subject |
25 Oct 2023
18:15 CEST |
EUROAPI SA |
Nouvelle gouvernance chez EUROAPI
|
20103015 Pharmaceuticals |
Other subject |
25 Oct 2023
18:15 CEST |
EUROAPI SA |
EUROAPI Announces New Governance
|
20103015 Pharmaceuticals |
Other subject |
24 Oct 2023
17:45 CEST |
EUROAPI SA |
EUROAPI Increases the Resources Allocated to the Liquidity Contract With Kepler Cheuvreux
|
20103015 Pharmaceuticals |
Other subject |
24 Oct 2023
17:45 CEST |
EUROAPI SA |
EUROAPI : Augmentation des moyens affectés au contrat de liquidité conclu avec Kepler Cheuvreux
|
20103015 Pharmaceuticals |
Other subject |
09 Oct 2023
17:45 CEST |
EUROAPI SA |
EUROAPI: Full-Year 2023 Outlook Revised Downwards
|
20103015 Pharmaceuticals |
Other subject |
09 Oct 2023
17:45 CEST |
EUROAPI SA |
EUROAPI : Objectifs 2023 revus à la baisse
|
20103015 Pharmaceuticals |
Other subject |
29 Aug 2023
07:00 CEST |
EUROAPI SA |
EUROAPI to Acquire BianoGMP to Strengthen its CDMO Expertise in the High-Growth oligonucleotide Market
|
20103015 Pharmaceuticals |
Other subject |
29 Aug 2023
07:00 CEST |
EUROAPI SA |
EUROAPI va acquérir BianoGMP pour renforcer son expertise CDMO sur le marché en forte croissance des oligonucléotides
|
20103015 Pharmaceuticals |
Other subject |
02 Aug 2023
17:45 CEST |
EUROAPI SA |
EUROAPI : Mise à disposition du Rapport financier semestriel 2023
|
20103015 Pharmaceuticals |
Corporate life |
02 Aug 2023
17:45 CEST |
EUROAPI SA |
EUROAPI: Availability of 2023 Half-Year Financial Report
|
20103015 Pharmaceuticals |
Corporate life |
01 Aug 2023
07:00 CEST |
EUROAPI SA |
EUROAPI: H1 2023 RESULTS
|
20103015 Pharmaceuticals |
Other subject |
01 Aug 2023
07:00 CEST |
EUROAPI SA |
EUROAPI : RESULTATS SEMESTRIELS 2023
|
20103015 Pharmaceuticals |
Other subject |
13 Jun 2023
13:55 CEST |
EUROAPI SA |
Health Sovereignty: EUROAPI Supports the Supply of Essential Medicines to France and Europe
|
20103015 Pharmaceuticals |
Other subject |
13 Jun 2023
13:55 CEST |
EUROAPI SA |
Souveraineté sanitaire : EUROAPI se mobilise en faveur de l’approvisionnement de la France et de l’Europe en médicaments essentiels
|
20103015 Pharmaceuticals |
Other subject |
06 Jun 2023
17:45 CEST |
EUROAPI SA |
EUROAPI to Invest €50 Million at Its Budapest Site to Meet the Growing Demand for Prostaglandins
|
20103015 Pharmaceuticals |
Other subject |
06 Jun 2023
17:45 CEST |
EUROAPI SA |
EUROAPI va investir 50 millions d’euros sur son site de Budapest pour répondre à la demande croissante de prostaglandines
|
20103015 Pharmaceuticals |
Other subject |
11 May 2023
18:00 CEST |
EUROAPI SA |
EUROAPI : Assemblée Générale Mixte du 11 mai 2023
|
20103015 Pharmaceuticals |
Other subject |
11 May 2023
18:00 CEST |
EUROAPI SA |
EUROAPI: Combined General Meeting of May 11, 2023
|
20103015 Pharmaceuticals |
Other subject |
10 May 2023
20:18 CEST |
EUROAPI SA |
EUROAPI’s Board of Directors Proposes Géraldine Leveau as Director
|
20103015 Pharmaceuticals |
Other subject |
10 May 2023
20:18 CEST |
EUROAPI SA |
Le Conseil d’administration d’EUROAPI propose Géraldine Leveau en tant qu’administrateur
|
20103015 Pharmaceuticals |
Other subject |
09 May 2023
07:00 CEST |
EUROAPI SA |
EUROAPI and Novéal sign CDMO agreement to advance cosmetic projects
|
20103015 Pharmaceuticals |
Other subject |
09 May 2023
07:00 CEST |
EUROAPI SA |
EUROAPI et Novéal signent un accord de CDMO pour des projets dans le domaine de la cosmétique
|
20103015 Pharmaceuticals |
Other subject |
26 Apr 2023
18:00 CEST |
EUROAPI SA |
EUROAPI: Availability of the Amendment n°1 of the 2022 Universal Registration Document
|
20103015 Pharmaceuticals |
Other subject |
26 Apr 2023
18:00 CEST |
EUROAPI SA |
EUROAPI : Mise à disposition de l’Amendement n°1 du Document d’Enregistrement Universel 2022
|
20103015 Pharmaceuticals |
Other subject |
14 Apr 2023
23:00 CEST |
EUROAPI SA |
EUROAPI: Availability of the 2022 Universal Registration Document, Including the Annual Financial Report
|
20103015 Pharmaceuticals |
Other subject |
14 Apr 2023
23:00 CEST |
EUROAPI SA |
EUROAPI : Mise à disposition du Document d’Enregistrement Universel 2022, contenant le Rapport Financier Annuel
|
20103015 Pharmaceuticals |
Other subject |
08 Mar 2023
07:00 CET |
EUROAPI SA |
EUROAPI: Full-Year 2022 Results
|
20103015 Pharmaceuticals |
Other subject |
08 Mar 2023
07:00 CET |
EUROAPI SA |
EUROAPI : RESULTATS ANNUELS 2022
|
20103015 Pharmaceuticals |
Other subject |
31 Jan 2023
07:00 CET |
EUROAPI SA |
EUROAPI: Progressive restart of prostaglandin production at Budapest site
|
20103015 Pharmaceuticals |
Other subject |
31 Jan 2023
07:00 CET |
EUROAPI SA |
EUROAPI : Redémarrage progressif de la production de prostaglandines sur le site de Budapest
|
20103015 Pharmaceuticals |
Other subject |
11 Jan 2023
18:00 CET |
EUROAPI SA |
EUROAPI’s Board of Directors Proposes Mattias Perjos as Independent Director
|
20103015 Pharmaceuticals |
Other subject |
11 Jan 2023
18:00 CET |
EUROAPI SA |
Le Conseil d’administration d’EUROAPI propose Mattias Perjos en tant qu’administrateur indépendant
|
20103015 Pharmaceuticals |
Other subject |
09 Jan 2023
07:00 CET |
EUROAPI SA |
Vitamine B12 : EUROAPI va investir 40 millions d’euros dans un procédé de production plus efficace et durable en France
|
20103015 Pharmaceuticals |
Other subject |
09 Jan 2023
07:00 CET |
EUROAPI SA |
Vitamin B12: EUROAPI to Invest €40 Million for a More Efficient and Sustainable Production Process in France
|
20103015 Pharmaceuticals |
Other subject |